North America Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Hemodialysis and Peritoneal Dialysis), Product (Devices, Consumables, and Services), and End User (Hospital-Based and Home-Based)
The hemodialysis and peritoneal dialysis market in North America is expected to grow from US$ 31,852.39 million in 2022 to US$ 45,277.56 million by 2028; it is estimated to grow at a CAGR of 6.0% from 2022 to 2028.
The rising prevalence of kidney diseases is the major factor driving the North America hemodialysis and peritoneal dialysis market. Chronic kidney disease (CKD) and acute kidney injury (AKI) are conditions in which the kidneys are damaged and cannot filter blood properly. Because of this, excess fluid and waste from blood remain in the body, which may cause other health problems such as heart disease and stroke. CKD usually worsens over time, even though treatment has shown slow progression. If CKD is left untreated, it can progress to kidney failure and early cardiovascular disease. In CKD, when the kidneys stop working, dialysis or kidney transplant is needed for survival. When treated with dialysis or kidney transplant, this kidney failure is called end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), approximately 36 million adults are suffering from CKD in the US. Further, every 24 hours, 360 people begin dialysis treatment for kidney failure. In 2017, 697.5 million cases of CKD (all stages) were recorded worldwide, with a North American prevalence of 9.1%.
In the past few years, the requirement for dialysis has increased. For instance, according to the National Kidney Foundation, in 2018, 785,883 US residents faced kidney failure, of which 554,038 received dialysis. Likewise, according to the data published by the Food & Drug Administration (FDA), about 10,000 children in the US develop AKI. These children have a survival rate of around 38% to 43%.
The increasing prevalence of ESRD is also one of the major factors driving the market. For instance, according to the United States Renal Data System (USRDS), nearly 786,000 people in the country are living with end-stage kidney disease (ESKD), also known as end-stage renal disease (ESRD). Thus, the increasing prevalence of chronic kidney disease, acute kidney injury, and end-stage renal disease, which leads to the condition of dialysis, is driving the hemodialysis and peritoneal dialysis market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America hemodialysis and peritoneal dialysis market. The North America hemodialysis and peritoneal dialysis market is expected to grow at a good CAGR during the forecast period.
North America Hemodialysis and Peritoneal DialysisMarket Revenue and Forecast to 2028 (US$ Million)
North America Hemodialysis and Peritoneal Dialysis Market Segmentation
The North America hemodialysis and peritoneal dialysis market is segmented into type, product, end user, and country. Based on type, the market is bifurcated into hemodialysis and peritoneal dialysis. In 2022, the hemodialysis segment is expected to hold a larger market share. Based on product, the hemodialysis and peritoneal dialysis market is segmented into devices, consumables, and services. The services segment is likely to hold the largest market share in 2022. Based on end user, the market is segmented into hospital-based and home-based. The hospital-based segment is expected to account for a larger share in 2022. Based on country, the North America hemodialysis and peritoneal dialysis market is segmented into the US, Canada, and Mexico. The US is anticipated to hold the largest market share in 2022.
Asahi Kasei Medical Co., Ltd.; B. Braun Melsungen AG; Baxter International Inc.; DaVita Inc.; Dialife SA; Evoqua Water Technologies LLC. (Mar Cor Purification); Fresenius Medical Care AG & Co KGaA; Nipro Medical Corporation; and Rockwell Medical, Inc. are among the leading companies operating in the North America hemodialysis and peritoneal dialysis market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Hemodialysis and Peritoneal Dialysis Market – By Type
1.3.2 North America Hemodialysis and Peritoneal Dialysis Market – By Product
1.3.3 North America Hemodialysis and Peritoneal Dialysis Market – By End User
1.3.4 North America Hemodialysis and Peritoneal Dialysis Market – By Country
2. North America Hemodialysis and Peritoneal Dialysis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hemodialysis and Peritoneal Dialysis Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Hemodialysis and Peritoneal Dialysis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Kidney Diseases
5.1.2 Increasing Cases of Diabetes
5.2 Market Restraints
5.2.1 Risks and Complications with Dialysis
5.3 Market Opportunities
5.3.1 Surge in Preference of Patients for Home Care Dialysis
5.4 Future Trends
5.4.1 Market Strategies by Major Players
5.5 Impact Analysis
6. Haemodialysis and Peritoneal Dialysis Market– North America Analysis
6.1 North America Haemodialysis and Peritoneal Dialysis Market Revenue Forecast and Analysis
6.2 North America Haemodialysis and Peritoneal Dialysis Market, By Country - Forecast and Analysis
7. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028– by Type
7.1 Overview
7.2 North America Haemodialysis and Peritoneal Dialysis Market, By Type, 2022 & 2028 (%)
7.3 Haemodialysis
7.3.1 Overview
7.3.2 Haemodialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Peritoneal Dialysis
7.4.1 Overview
7.4.2 Peritoneal Dialysis: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – Product
8.1 Overview
8.2 North America Haemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
8.3 Devices
8.3.1 Overview
8.3.2 Devices: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.4 Consumables
8.4.1 Overview
8.4.2 Consumables: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
8.5 Services
8.5.1 Overview
8.5.2 Services: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 North America Haemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
9.3 Hospital-Based
9.3.1 Overview
9.3.2 Hospital-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
9.4 Home-Based
9.4.1 Overview
9.4.2 Home-Based: Haemodialysis and Peritoneal Dialysis Market Revenue and Forecast to 2028 (US$ Million)
10. North America Haemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 North America: Haemodialysis and Peritoneal Dialysis Market, by Country, 2022 & 2028 (%)
10.1.1.1 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 US: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.1.4 US: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.1.5 US: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
10.1.1.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Canada: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.2.4 Canada: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.2.5 Canada: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
10.1.1.3 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Type, 2019–2028 (US$ Million)
10.1.1.3.4 Mexico: Haemodialysis and Peritoneal Dialysis Market, by Product, 2019–2028 (US$ Million)
10.1.1.3.5 Mexico: Haemodialysis and Peritoneal Dialysis Market, by End User, 2019–2028 (US$ Million)
11. Hemodialysis and Peritoneal Dialysis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Fresenius Medical Care AG & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DaVita Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Baxter International Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 B. Braun Melsungen AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nipro Medical Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Evoqua Water Technologies LLC. (Mar Cor Purification)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Medical Co., Ltd.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Rockwell Medical, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Dialife SA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 3. US Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Haemodialysis and Peritoneal Dialysis Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Haemodialysis and Peritoneal Dialysis Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Haemodialysis and Peritoneal Dialysis Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments in the Hemodialysis and Peritoneal Dialysis Market
Table 11. Inorganic Developments in the Hemodialysis and Peritoneal Dialysis Market
Table 12. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Hemodialysis and Peritoneal Dialysis Market Segmentation
Figure 2. North America Hemodialysis and Peritoneal Dialysis Market Segmentation, By Country
Figure 3. North America Hemodialysis and Peritoneal Dialysis Market Overview
Figure 4. Hemodialysis Segment Held Largest Share by Type in North America Hemodialysis and Peritoneal Dialysis Market
Figure 5. Canada Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints North America Pertaining to Hemodialysis and Peritoneal Dialysis Market
Figure 8. North America Hemodialysis and Peritoneal Dialysis Market – By Country Forecast and Analysis – 2022 - 2028
Figure 9. North America Hemodialysis and Peritoneal Dialysis Market, by Type, 2022 & 2028 (%)
Figure 10. North America Hemodialysis: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
Figure 11. North America Peritoneal Dialysis: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. North America Hemodialysis and Peritoneal Dialysis Market Share by Product Segment - 2021 & 2028 (%)
Figure 13. North America Devices: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 (US$ Million)
Figure 14. North America Consumables: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 (US$ Million)
Figure 15. North America Services: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 (US$ Million)
Figure 16. North America Hemodialysis and Peritoneal Dialysis Market Share by End User Segment - 2021 & 2028 (%)
Figure 17. North America Hospital-Based: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. North America Home-Based: Hemodialysis and Peritoneal Dialysis Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. North America: Haemodialysis and Peritoneal Dialysis Market, by Key Country – Revenue (2022) (US$ Million)
Figure 20. North America: Haemodialysis and Peritoneal Dialysis Market, by Country, 2022 & 2028 (%)
Figure 21. US: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Canada: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Mexico: Haemodialysis and Peritoneal Dialysis Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Growth Strategies in the Hemodialysis and Peritoneal Dialysis Market (%)
- Asahi Kasei Medical Co., Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- DaVita Inc.
- Dialife SA
- Evoqua Water Technologies LLC. (Mar Cor Purification)
- Fresenius Medical Care AG & Co KGaA
- Nipro Medical Corporation
- Rockwell Medical, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America hemodialysis and peritoneal dialysis market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America hemodialysis and peritoneal dialysis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the hemodialysis and peritoneal dialysis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution